Bile duct resection

By -

 

Executive Summary

Bile duct resection, specifically for tumors at the confluence of the left and right hepatic ducts, is characterized as one of the most complex and difficult procedures in hepatobiliary surgery. The primary objective is the radical removal of hilar cholangiocarcinoma or similar malignancies. The procedure necessitates a multi-faceted approach involving portal lymphadenectomy, bile duct resection, and—almost invariably—liver resection.

The three fundamental goals of the operation are:

  1. Complete resection of the primary tumor.

  2. Resection of the lymphatic drainage pathways of the liver.

  3. Reestablishment of biliary continuity through reconstruction.

Successful outcomes depend on meticulous preoperative investigation (including radiology and CT volumetry), strategic preoperative biliary drainage, and precise intraoperative management of vascular and biliary structures. Key risks include bile leaks, liver failure, and long-term complications such as cholangitis and anastomotic strictures.

Indications and Contraindications

The selection of patients for bile duct resection is governed by the nature of the malignancy and the patient's physiological reserves.

Indications

  • Primary Malignancies: Intrahepatic cholangiocarcinoma involving the hepatic hilus, hilar cholangiocarcinoma, gallbladder carcinoma involving the hepatic hilus, and diffuse carcinoma of the extrahepatic bile duct.

  • Benign Diseases: Primary sclerosing cholangitis (PSC) and inflammatory pseudotumors.

  • Trauma: Traumatic lesions located at the hepatic hilus.

Contraindications

The feasibility of surgery is limited by the extent of the disease and the functional capacity of the liver.

Category

Conditions

Absolute Contraindications

Distant organ metastasis (liver, lung, bone, peritoneum); uncontrollable severe cholangitis (with or without sepsis); poor liver reserve exacerbated by prolonged cholestasis; severe coagulopathy despite vitamin K administration.

Relative Contraindications

Cholangiocarcinoma with para-aortic lymph node metastasis.

Critical Note: A metallic stent should not be used in cases of resectable biliary carcinoma.

Preoperative Investigation and Preparation

Preoperative Investigation

A comprehensive diagnostic workup is required to determine the intraductal spread of cancer and define the surgical margin.

  • History & Clinical Evaluation: Focused on previous biliary surgery, jaundice, cholangitis, and nutritional status.

  • Laboratory Tests: Standard liver function tests (Bilirubin, ALP, AST, ALT, albumin), coagulation parameters, indocyanine green test, and tumor markers (CA 19-9, CEA).

  • Radiology: A combination of Ultrasonography, MRCP, MDCT cholangiography, PTC, ERCP, 3D angiography, and CT volumetry.

  • Endoscopy: Peroral and percutaneous transhepatic cholangioscopy are utilized for differential diagnosis and biopsy.

Preparation Prior to Surgery

  • Biliary Drainage: Options include antibiotics sensitive to bile culture and percutaneous transhepatic biliary drainage (PTBD). Notably, endoscopic nasobiliary drainage (ENBD) is generally considered not advisable.

  • Nutritional Support: Internal biliary drainage or bile replacement via nasogastric tube for patients with external drainage.

  • Portal Vein Embolization (PVE): Recommended for patients undergoing major hepatectomy to ensure sufficient remnant liver volume.

Surgical Procedure: Systematic Approach

Step 1–4: Initial Exposure and Dissection

  1. Exposure and Exploration: Following incision and division of the round and falciform ligaments, ultrasound is used to locate the tumor relative to the portal vein, hepatic artery, and hepatic vein.

  2. Lymph Node Dissection: Systematic dissection of regional lymph nodes (No. 12, 8, 9, 13) and nerve plexuses around the hepatic artery.

  1. Distal Bile Duct Resection: The Kocher maneuver is performed to mobilize the duodenum. The distal bile duct is divided above the pancreas, and the resection margin must be confirmed as clear via frozen section.

  1. Skeletonization: The upper hepatoduodenal ligament is skeletonized, and the right and left portal veins are encircled.


Left Hepatic Resection (Steps 5–12)

This procedure is indicated for hilar cholangiocarcinoma predominantly involving the left intrahepatic bile ducts.

  • Vascular Control: The left and middle hepatic arteries are divided at the origin, followed by the ligation and division of the left portal vein.

  • Mobilization: The caudate lobe is mobilized by dividing the short hepatic veins. For left hepatectomy, the common trunk of the left and middle hepatic veins is transected.

  • Liver Transection: Following devascularization, dorsal demarcation appears between the caudate process and segment 7. The liver capsule is incised, and draining veins of the paracaval segment (segment 9) are divided.

  • Intrahepatic Resection: The incision extends to open segmental or subsegmental bile ducts (Segment 8, 1, and 5) to ensure tumor clearance.

Right Hepatic Resection (Steps 5–12)

Indicated for malignancies involving the right intrahepatic ducts.

  • Vascular Control: The right hepatic artery and right portal vein are ligated.

  • Mobilization: The right liver is mobilized, and short hepatic veins are divided. The right hepatic vein is transected using vascular clamps or a stapler.

  • Transection: Dissection follows the Cantlie line, roughly 1 cm above the hilar plate, to maintain surgical margins and reach the right edge of the Rex recess.

  • Bile Duct Access: The left intrahepatic bile duct is transected perpendicularly at the right edge of the Rex recess to remove the right liver, caudate lobe, and extrahepatic bile duct.

Step 13–14: Reconstruction and Drainage

  • Biliary Reconstruction: Hepaticoplasty is performed using 5-0 PDS sutures to minimize the number of anastomoses. A Roux-en-Y jejunal loop is then lifted for hepaticojejunostomy.

  • Drainage: Closed drains are placed in the foramen of Winslow, the paracaval space, and along the liver's cut surface. External biliary drainage and jejunostomy tubes are utilized postoperatively.

Postoperative Management and Complications

Surveillance and Testing

  • Intensive or intermediate care unit surveillance.

  • Regular liver function tests and coagulation parameters.

  • Color Doppler ultrasound to monitor blood flow in the portal vein and hepatic artery.

Complications

Short-term

Long-term

Pleural effusion, wound infection, liver failure, intra-abdominal bleeding, portal vein thrombosis.

Cholangitis.

Bile leak: From the hepaticojejunostomy or the raw liver surface.

Stricture: Anastomotic stricture.

Subphrenic or subhepatic abscess.

Chronic liver failure.

Critical Surgical Insights (Tricks of the Senior Surgeon)

  • Biliary Congestion: Always check intraoperative external biliary drainage to prevent unexpected congestion and subsequent sepsis.

  • CVP Management: Monitor central venous pressure (CVP) before liver transection; if CVP is higher than 3 cm H₂O, the transection should not begin.

  • Vascular Safety: Close the hepatic vein on the liver side with a running suture to prevent bleeding during handling.

  • Anastomotic Integrity: Place stay sutures before dividing intrahepatic bile ducts to prevent small segmental ducts from retracting into the liver parenchyma.

  • Lymphatic Management: Tie lymphatic vessels during para-aortic lymph node dissection to prevent postoperative massive lymphorrhea.

Editor's Final Comments

The editor notes that tissue diagnosis is not a prerequisite for resection if clinical and radiographic evidence is sufficient. ERCP and peroral cholangioscopy should be avoided for high bile duct obstructions to prevent cholangitis. Percutaneous drainage is the preferred method for those with renal dysfunction or those requiring portal vein embolization.